NEW
YORK, July 24, 2024 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by Pieris
Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors
concerning the proposed acquisition of the company by Palvella
Therapeutics, Inc. Pieris Pharmaceuticals stockholders are expected
to own approximately 18% of the combined company. The transaction
is expected to close in the fourth quarter of 2024.
If you are a stockholder of Pieris Pharmaceuticals, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/pirs/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-pieris-pharmaceuticals-inc-302205623.html
SOURCE Rowley Law PLLC